| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 42 | 2025 | 943 | 2.640 |
Why?
|
| Computational Biology | 12 | 2020 | 821 | 2.030 |
Why?
|
| Genetic Diseases, Inborn | 15 | 2024 | 446 | 1.930 |
Why?
|
| Comparative Genomic Hybridization | 27 | 2017 | 573 | 1.790 |
Why?
|
| Software | 6 | 2020 | 686 | 1.750 |
Why?
|
| Chromosome Aberrations | 23 | 2019 | 621 | 1.540 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 43 | 2025 | 1019 | 1.470 |
Why?
|
| Disease | 4 | 2020 | 129 | 1.300 |
Why?
|
| Chromosome Disorders | 17 | 2019 | 312 | 1.240 |
Why?
|
| Genome, Human | 24 | 2025 | 1273 | 1.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2020 | 871 | 1.190 |
Why?
|
| Models, Statistical | 3 | 2020 | 471 | 1.170 |
Why?
|
| Mosaicism | 10 | 2020 | 241 | 1.170 |
Why?
|
| Blood Platelets | 9 | 2019 | 326 | 1.110 |
Why?
|
| Models, Theoretical | 3 | 2020 | 359 | 1.090 |
Why?
|
| Gene Expression Regulation | 25 | 2023 | 2539 | 1.090 |
Why?
|
| Phenotype | 28 | 2022 | 4260 | 1.010 |
Why?
|
| Sequence Analysis, DNA | 12 | 2020 | 1760 | 0.940 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2019 | 2626 | 0.840 |
Why?
|
| Gene Dosage | 15 | 2013 | 441 | 0.840 |
Why?
|
| Genome-Wide Association Study | 12 | 2019 | 1675 | 0.830 |
Why?
|
| Microbiota | 5 | 2020 | 391 | 0.790 |
Why?
|
| Codon, Nonsense | 3 | 2021 | 132 | 0.790 |
Why?
|
| Nonsense Mediated mRNA Decay | 2 | 2021 | 29 | 0.790 |
Why?
|
| Genomic Instability | 9 | 2018 | 229 | 0.700 |
Why?
|
| Respiratory Syncytial Virus, Human | 4 | 2017 | 203 | 0.680 |
Why?
|
| Exons | 10 | 2025 | 796 | 0.670 |
Why?
|
| Humans | 167 | 2025 | 124822 | 0.660 |
Why?
|
| Genetic Techniques | 2 | 2018 | 106 | 0.650 |
Why?
|
| Exome | 13 | 2022 | 1042 | 0.650 |
Why?
|
| Mutation | 23 | 2024 | 5815 | 0.640 |
Why?
|
| Microarray Analysis | 6 | 2019 | 230 | 0.640 |
Why?
|
| Gene Expression Profiling | 22 | 2016 | 1699 | 0.620 |
Why?
|
| Algorithms | 6 | 2024 | 1616 | 0.620 |
Why?
|
| Gametogenesis | 3 | 2017 | 24 | 0.620 |
Why?
|
| Genetic Testing | 6 | 2024 | 1004 | 0.600 |
Why?
|
| Bayes Theorem | 3 | 2020 | 283 | 0.590 |
Why?
|
| Chromosome Deletion | 14 | 2023 | 647 | 0.590 |
Why?
|
| MicroRNAs | 10 | 2015 | 841 | 0.570 |
Why?
|
| Models, Genetic | 11 | 2019 | 759 | 0.570 |
Why?
|
| Genes, Reporter | 2 | 2018 | 383 | 0.570 |
Why?
|
| Genomics | 12 | 2022 | 1491 | 0.560 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2017 | 341 | 0.550 |
Why?
|
| Genetic Variation | 10 | 2020 | 1493 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 12 | 2016 | 1113 | 0.540 |
Why?
|
| Sequence Deletion | 12 | 2018 | 528 | 0.540 |
Why?
|
| Quantitative Trait Loci | 3 | 2019 | 284 | 0.540 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 3143 | 0.530 |
Why?
|
| Alleles | 10 | 2019 | 1619 | 0.530 |
Why?
|
| In Situ Hybridization, Fluorescence | 26 | 2016 | 764 | 0.520 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 87 | 0.510 |
Why?
|
| Gene Duplication | 10 | 2018 | 358 | 0.510 |
Why?
|
| Inheritance Patterns | 3 | 2017 | 124 | 0.510 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1473 | 0.500 |
Why?
|
| Germ-Line Mutation | 2 | 2014 | 333 | 0.500 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 144 | 0.480 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 237 | 0.480 |
Why?
|
| Breast Neoplasms | 10 | 2019 | 2513 | 0.480 |
Why?
|
| Protein Interaction Mapping | 2 | 2014 | 85 | 0.470 |
Why?
|
| RNA, Messenger | 14 | 2016 | 2825 | 0.460 |
Why?
|
| Nucleic Acid Hybridization | 9 | 2010 | 395 | 0.440 |
Why?
|
| Abnormalities, Multiple | 10 | 2023 | 963 | 0.430 |
Why?
|
| Spinocerebellar Ataxias | 6 | 2013 | 252 | 0.430 |
Why?
|
| Nuclear Proteins | 13 | 2024 | 1272 | 0.420 |
Why?
|
| Transcription, Genetic | 16 | 2017 | 1704 | 0.420 |
Why?
|
| Trophoblasts | 3 | 2019 | 114 | 0.420 |
Why?
|
| Female | 90 | 2024 | 66580 | 0.420 |
Why?
|
| Metagenomics | 1 | 2014 | 102 | 0.420 |
Why?
|
| Receptors, Thrombin | 4 | 2018 | 12 | 0.420 |
Why?
|
| Epilepsy | 4 | 2013 | 874 | 0.420 |
Why?
|
| Bronchiolitis | 3 | 2019 | 120 | 0.410 |
Why?
|
| Gene Deletion | 6 | 2018 | 795 | 0.400 |
Why?
|
| Animals | 70 | 2024 | 34195 | 0.390 |
Why?
|
| Viral Proteins | 1 | 2014 | 348 | 0.390 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 6 | 2015 | 309 | 0.390 |
Why?
|
| Homologous Recombination | 7 | 2022 | 92 | 0.370 |
Why?
|
| Mice | 48 | 2023 | 17747 | 0.370 |
Why?
|
| Rare Diseases | 2 | 2024 | 192 | 0.370 |
Why?
|
| Single-Cell Analysis | 5 | 2019 | 275 | 0.370 |
Why?
|
| Genotype | 14 | 2018 | 2557 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2019 | 370 | 0.360 |
Why?
|
| Male | 79 | 2024 | 61314 | 0.360 |
Why?
|
| Base Sequence | 16 | 2022 | 3100 | 0.360 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2013 | 543 | 0.350 |
Why?
|
| Gene Regulatory Networks | 5 | 2016 | 355 | 0.340 |
Why?
|
| Platelet Activation | 3 | 2015 | 71 | 0.330 |
Why?
|
| Autistic Disorder | 6 | 2013 | 350 | 0.320 |
Why?
|
| Cell Line, Tumor | 15 | 2019 | 3342 | 0.310 |
Why?
|
| DNA Replication | 5 | 2019 | 352 | 0.310 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 721 | 0.300 |
Why?
|
| Alu Elements | 3 | 2018 | 65 | 0.300 |
Why?
|
| Dictyostelium | 6 | 2004 | 114 | 0.300 |
Why?
|
| Repressor Proteins | 6 | 2021 | 820 | 0.300 |
Why?
|
| Signal Transduction | 11 | 2019 | 4543 | 0.290 |
Why?
|
| Circadian Rhythm | 5 | 2007 | 274 | 0.290 |
Why?
|
| Genetic Markers | 4 | 2019 | 606 | 0.290 |
Why?
|
| Neoplasms | 2 | 2021 | 2789 | 0.280 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 3882 | 0.280 |
Why?
|
| Polymerase Chain Reaction | 9 | 2015 | 1588 | 0.280 |
Why?
|
| Nasopharynx | 2 | 2018 | 79 | 0.270 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2012 | 82 | 0.270 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2022 | 401 | 0.270 |
Why?
|
| Genotyping Techniques | 3 | 2016 | 103 | 0.270 |
Why?
|
| Nasal Cavity | 2 | 2018 | 50 | 0.270 |
Why?
|
| Intellectual Disability | 8 | 2017 | 1061 | 0.260 |
Why?
|
| Gene Expression | 7 | 2016 | 1569 | 0.260 |
Why?
|
| Transcriptome | 5 | 2016 | 940 | 0.260 |
Why?
|
| Platelet Aggregation | 3 | 2015 | 121 | 0.260 |
Why?
|
| Ataxia | 3 | 2014 | 168 | 0.250 |
Why?
|
| DNA Methylation | 5 | 2019 | 1004 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2017 | 215 | 0.250 |
Why?
|
| Phospholipid Transfer Proteins | 2 | 2017 | 15 | 0.250 |
Why?
|
| Membrane Proteins | 7 | 2017 | 1527 | 0.250 |
Why?
|
| Gene Rearrangement | 5 | 2019 | 321 | 0.250 |
Why?
|
| Homozygote | 3 | 2019 | 534 | 0.250 |
Why?
|
| Genes, Viral | 2 | 2017 | 185 | 0.250 |
Why?
|
| INDEL Mutation | 3 | 2020 | 87 | 0.240 |
Why?
|
| Pregnancy | 12 | 2020 | 7172 | 0.240 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2018 | 19 | 0.240 |
Why?
|
| DNA Repair | 4 | 2019 | 587 | 0.240 |
Why?
|
| Cell Differentiation | 11 | 2019 | 1929 | 0.240 |
Why?
|
| Trisomy | 4 | 2011 | 103 | 0.240 |
Why?
|
| Receptor, ErbB-2 | 2 | 2019 | 514 | 0.230 |
Why?
|
| Germ Cells | 3 | 2014 | 194 | 0.230 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 280 | 0.230 |
Why?
|
| Bronchiolitis, Viral | 2 | 2016 | 30 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2017 | 86 | 0.230 |
Why?
|
| Hypothalamus | 3 | 2013 | 221 | 0.230 |
Why?
|
| Translocation, Genetic | 4 | 2012 | 356 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2019 | 100 | 0.230 |
Why?
|
| Interferons | 2 | 2017 | 124 | 0.230 |
Why?
|
| DNA Helicases | 4 | 2024 | 227 | 0.230 |
Why?
|
| Anophthalmos | 1 | 2024 | 24 | 0.220 |
Why?
|
| Gene Amplification | 2 | 2014 | 228 | 0.220 |
Why?
|
| Coloboma | 1 | 2024 | 45 | 0.220 |
Why?
|
| Microphthalmos | 1 | 2024 | 60 | 0.220 |
Why?
|
| Genes, myc | 2 | 2015 | 100 | 0.220 |
Why?
|
| DNA | 7 | 2016 | 1604 | 0.220 |
Why?
|
| Prevotella | 2 | 2020 | 8 | 0.220 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 1328 | 0.210 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2018 | 235 | 0.210 |
Why?
|
| Genome, Viral | 1 | 2024 | 168 | 0.210 |
Why?
|
| Developmental Disabilities | 6 | 2016 | 709 | 0.210 |
Why?
|
| Neoplasm Metastasis | 5 | 2017 | 670 | 0.210 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2022 | 16 | 0.210 |
Why?
|
| Anorectal Malformations | 1 | 2022 | 13 | 0.200 |
Why?
|
| Scimitar Syndrome | 1 | 2023 | 52 | 0.200 |
Why?
|
| Moraxella | 2 | 2019 | 14 | 0.200 |
Why?
|
| Virus Replication | 2 | 2024 | 611 | 0.200 |
Why?
|
| Child, Preschool | 23 | 2024 | 14054 | 0.200 |
Why?
|
| DNA-Binding Proteins | 5 | 2015 | 2060 | 0.200 |
Why?
|
| Streptococcus | 2 | 2019 | 61 | 0.200 |
Why?
|
| Esophageal Atresia | 1 | 2022 | 51 | 0.200 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2022 | 48 | 0.200 |
Why?
|
| Mixed Function Oxygenases | 2 | 2012 | 30 | 0.190 |
Why?
|
| Adult | 24 | 2024 | 29484 | 0.190 |
Why?
|
| Infant | 19 | 2024 | 12488 | 0.190 |
Why?
|
| Smith-Magenis Syndrome | 3 | 2019 | 105 | 0.190 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 69 | 0.190 |
Why?
|
| RNA, Viral | 1 | 2024 | 541 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 17 | 2016 | 4429 | 0.190 |
Why?
|
| Prenatal Diagnosis | 5 | 2019 | 597 | 0.190 |
Why?
|
| Cell Line | 9 | 2019 | 2770 | 0.190 |
Why?
|
| Cell Proliferation | 6 | 2017 | 2307 | 0.180 |
Why?
|
| MEF2 Transcription Factors | 2 | 2019 | 42 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2011 | 140 | 0.180 |
Why?
|
| Telomere | 4 | 2008 | 212 | 0.180 |
Why?
|
| Karyotyping | 9 | 2014 | 331 | 0.180 |
Why?
|
| Chromosome Breakpoints | 6 | 2019 | 80 | 0.180 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 157 | 0.180 |
Why?
|
| Mutation Rate | 3 | 2024 | 66 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2011 | 73 | 0.180 |
Why?
|
| Young Adult | 13 | 2019 | 8993 | 0.180 |
Why?
|
| Staphylococcus | 2 | 2018 | 70 | 0.180 |
Why?
|
| Thrombosis | 3 | 2015 | 522 | 0.180 |
Why?
|
| Myocytes, Cardiac | 4 | 2023 | 623 | 0.180 |
Why?
|
| Transcription Factors | 7 | 2024 | 2609 | 0.170 |
Why?
|
| Rett Syndrome | 3 | 2015 | 291 | 0.170 |
Why?
|
| Chromosome Mapping | 9 | 2023 | 1082 | 0.170 |
Why?
|
| Hospitals | 1 | 2023 | 398 | 0.170 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2015 | 81 | 0.170 |
Why?
|
| Hematopoiesis | 3 | 2014 | 220 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2018 | 888 | 0.170 |
Why?
|
| Cytogenetic Analysis | 5 | 2012 | 79 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2023 | 527 | 0.170 |
Why?
|
| Pyridines | 2 | 2018 | 230 | 0.170 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 19 | 0.170 |
Why?
|
| CD36 Antigens | 1 | 2019 | 37 | 0.160 |
Why?
|
| Nasal Mucosa | 1 | 2019 | 65 | 0.160 |
Why?
|
| Respiratory Sounds | 1 | 2019 | 69 | 0.160 |
Why?
|
| Child | 24 | 2024 | 24463 | 0.160 |
Why?
|
| Coronary Vessels | 1 | 2023 | 541 | 0.160 |
Why?
|
| Thrombopoiesis | 1 | 2019 | 11 | 0.160 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 370 | 0.160 |
Why?
|
| Cohort Studies | 11 | 2018 | 4786 | 0.160 |
Why?
|
| Rhinovirus | 2 | 2016 | 59 | 0.160 |
Why?
|
| Trinucleotide Repeat Expansion | 3 | 2015 | 124 | 0.160 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 31 | 0.160 |
Why?
|
| Osteochondrodysplasias | 2 | 2012 | 68 | 0.150 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 25 | 0.150 |
Why?
|
| Megakaryocytes | 1 | 2019 | 43 | 0.150 |
Why?
|
| Lactones | 1 | 2018 | 39 | 0.150 |
Why?
|
| Disease Models, Animal | 13 | 2017 | 4356 | 0.150 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 123 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 221 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2011 | 160 | 0.150 |
Why?
|
| Myocardium | 3 | 2007 | 1008 | 0.150 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 482 | 0.150 |
Why?
|
| Adolescent | 19 | 2024 | 19333 | 0.150 |
Why?
|
| WAGR Syndrome | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cell Cycle Proteins | 3 | 2018 | 647 | 0.150 |
Why?
|
| Influenza, Human | 2 | 2015 | 658 | 0.150 |
Why?
|
| Biological Assay | 1 | 2018 | 101 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2015 | 777 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 105 | 0.140 |
Why?
|
| Evolution, Molecular | 4 | 2024 | 674 | 0.140 |
Why?
|
| Databases, Genetic | 4 | 2018 | 473 | 0.140 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2017 | 35 | 0.140 |
Why?
|
| Aneuploidy | 3 | 2014 | 155 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2015 | 618 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 1291 | 0.140 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.140 |
Why?
|
| Influenza Vaccines | 2 | 2013 | 478 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 354 | 0.140 |
Why?
|
| Phosphofructokinase-1 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 1816 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2019 | 325 | 0.140 |
Why?
|
| Paracrine Communication | 1 | 2017 | 70 | 0.140 |
Why?
|
| Chromosome Breakage | 6 | 2011 | 168 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 1351 | 0.140 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2016 | 3 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 213 | 0.140 |
Why?
|
| Hormones | 1 | 2017 | 187 | 0.140 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 195 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2014 | 118 | 0.130 |
Why?
|
| Ataxins | 6 | 2013 | 114 | 0.130 |
Why?
|
| Influenza B virus | 2 | 2015 | 87 | 0.130 |
Why?
|
| CELF1 Protein | 1 | 2016 | 48 | 0.130 |
Why?
|
| Loss of Heterozygosity | 2 | 2015 | 125 | 0.130 |
Why?
|
| Pedigree | 6 | 2019 | 1595 | 0.130 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2016 | 66 | 0.130 |
Why?
|
| Heterotaxy Syndrome | 1 | 2016 | 61 | 0.130 |
Why?
|
| Myocardial Contraction | 2 | 2007 | 265 | 0.130 |
Why?
|
| Recombination, Genetic | 3 | 2019 | 450 | 0.130 |
Why?
|
| Transgenes | 2 | 2014 | 337 | 0.130 |
Why?
|
| Pharynx | 1 | 2016 | 64 | 0.130 |
Why?
|
| Antigens, Viral | 2 | 2017 | 438 | 0.130 |
Why?
|
| Prognosis | 3 | 2021 | 4615 | 0.130 |
Why?
|
| Ataxin-1 | 6 | 2013 | 162 | 0.130 |
Why?
|
| Picornaviridae Infections | 1 | 2016 | 48 | 0.130 |
Why?
|
| Carrier Proteins | 3 | 2018 | 1027 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 5 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 471 | 0.130 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2015 | 16 | 0.130 |
Why?
|
| Epithelial Cells | 3 | 2016 | 910 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 266 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2015 | 80 | 0.120 |
Why?
|
| Receptors, IgG | 1 | 2015 | 58 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 507 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 3 | 2015 | 147 | 0.120 |
Why?
|
| Endonucleases | 1 | 2015 | 54 | 0.120 |
Why?
|
| Data Mining | 1 | 2015 | 54 | 0.120 |
Why?
|
| Spliceosomes | 1 | 2015 | 53 | 0.120 |
Why?
|
| Drosophila | 3 | 2015 | 781 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 757 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 22 | 3 | 2012 | 103 | 0.120 |
Why?
|
| DNA, Mitochondrial | 2 | 2009 | 211 | 0.120 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2015 | 35 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2023 | 16296 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2016 | 1402 | 0.120 |
Why?
|
| Infant, Newborn | 12 | 2017 | 8189 | 0.120 |
Why?
|
| Biomarkers | 3 | 2020 | 3063 | 0.120 |
Why?
|
| Primates | 1 | 2015 | 80 | 0.120 |
Why?
|
| Chorionic Villi Sampling | 2 | 2012 | 45 | 0.120 |
Why?
|
| Chromosome Duplication | 4 | 2019 | 147 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2017 | 506 | 0.120 |
Why?
|
| Endogenous Retroviruses | 1 | 2014 | 17 | 0.120 |
Why?
|
| Uniparental Disomy | 1 | 2015 | 49 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2014 | 348 | 0.120 |
Why?
|
| Williams Syndrome | 2 | 2012 | 39 | 0.120 |
Why?
|
| Blood Cells | 1 | 2014 | 49 | 0.120 |
Why?
|
| Amniocentesis | 2 | 2012 | 78 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 198 | 0.110 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 12 | 0.110 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2014 | 10 | 0.110 |
Why?
|
| Wilms Tumor | 1 | 2015 | 113 | 0.110 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2015 | 133 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2017 | 313 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2019 | 1626 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 171 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 70 | 0.110 |
Why?
|
| Contig Mapping | 1 | 2014 | 55 | 0.110 |
Why?
|
| Proteome | 2 | 2014 | 243 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2012 | 150 | 0.110 |
Why?
|
| Fathers | 1 | 2014 | 68 | 0.110 |
Why?
|
| Recurrence | 2 | 2014 | 1427 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2014 | 112 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2017 | 2883 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 1944 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 481 | 0.110 |
Why?
|
| Rotavirus Infections | 1 | 2017 | 354 | 0.110 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2013 | 32 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1109 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 30 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 470 | 0.110 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 37 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 276 | 0.110 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 27 | 0.110 |
Why?
|
| Barrett Esophagus | 2 | 2009 | 339 | 0.110 |
Why?
|
| Fragile X Syndrome | 1 | 2014 | 150 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 42 | 0.100 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2008 | 93 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2014 | 133 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2014 | 480 | 0.100 |
Why?
|
| Fetus | 1 | 2016 | 584 | 0.100 |
Why?
|
| DNA Primers | 1 | 2014 | 660 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 292 | 0.100 |
Why?
|
| Tremor | 1 | 2014 | 130 | 0.100 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2013 | 115 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 59 | 0.100 |
Why?
|
| Cell Communication | 2 | 2003 | 167 | 0.100 |
Why?
|
| Chromosomes, Human | 3 | 2008 | 130 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 119 | 0.100 |
Why?
|
| Down-Regulation | 5 | 2017 | 701 | 0.100 |
Why?
|
| Genes, Recessive | 1 | 2013 | 179 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 93 | 0.100 |
Why?
|
| Bone and Bones | 2 | 2019 | 267 | 0.100 |
Why?
|
| ras Proteins | 1 | 2013 | 137 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 271 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 207 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 3 | 2024 | 374 | 0.100 |
Why?
|
| Platelet Adhesiveness | 1 | 2012 | 40 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2012 | 59 | 0.100 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 5 | 0.100 |
Why?
|
| Cerebellum | 3 | 2011 | 416 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2012 | 30 | 0.100 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 22 | 0.100 |
Why?
|
| Carnitine | 1 | 2012 | 75 | 0.100 |
Why?
|
| Language Development Disorders | 1 | 2013 | 175 | 0.100 |
Why?
|
| Heart | 2 | 2007 | 724 | 0.100 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 23 | 0.100 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2012 | 58 | 0.100 |
Why?
|
| Nephrotic Syndrome | 1 | 2012 | 46 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 171 | 0.090 |
Why?
|
| Phylogeny | 1 | 2014 | 697 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 178 | 0.090 |
Why?
|
| Arteriosclerosis | 1 | 2012 | 145 | 0.090 |
Why?
|
| Texas | 3 | 2017 | 3592 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2014 | 319 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 72 | 0.090 |
Why?
|
| Syndrome | 5 | 2014 | 1118 | 0.090 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 674 | 0.090 |
Why?
|
| Mothers | 1 | 2014 | 354 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 431 | 0.090 |
Why?
|
| Cartilage | 2 | 2008 | 49 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2008 | 1001 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2012 | 155 | 0.090 |
Why?
|
| Frameshift Mutation | 2 | 2022 | 180 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2019 | 963 | 0.090 |
Why?
|
| Sexual Development | 1 | 2010 | 23 | 0.090 |
Why?
|
| Chromosome Banding | 4 | 2014 | 139 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 114 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 57 | 0.090 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 2410 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2018 | 720 | 0.090 |
Why?
|
| Family Health | 1 | 2011 | 259 | 0.090 |
Why?
|
| Cell Survival | 3 | 2018 | 807 | 0.090 |
Why?
|
| Social Behavior | 1 | 2012 | 209 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1894 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 273 | 0.090 |
Why?
|
| Autism Spectrum Disorder | 1 | 2015 | 393 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1668 | 0.090 |
Why?
|
| Interleukin-13 | 1 | 2010 | 96 | 0.080 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2012 | 205 | 0.080 |
Why?
|
| Medical Records | 1 | 2010 | 192 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2010 | 159 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2011 | 154 | 0.080 |
Why?
|
| Purkinje Cells | 2 | 2014 | 159 | 0.080 |
Why?
|
| Sensitivity and Specificity | 7 | 2009 | 2043 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 711 | 0.080 |
Why?
|
| Middle Aged | 9 | 2018 | 26730 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 178 | 0.080 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 58 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2010 | 142 | 0.080 |
Why?
|
| Inhibin-beta Subunits | 1 | 2009 | 18 | 0.080 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2012 | 199 | 0.080 |
Why?
|
| Sex Chromosomes | 1 | 2009 | 34 | 0.080 |
Why?
|
| Microdissection | 1 | 2009 | 12 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2012 | 491 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2010 | 114 | 0.080 |
Why?
|
| Cells, Cultured | 6 | 2013 | 3061 | 0.080 |
Why?
|
| Brain | 4 | 2016 | 3010 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 65 | 0.080 |
Why?
|
| Schizophrenia | 1 | 2011 | 302 | 0.080 |
Why?
|
| De Lange Syndrome | 2 | 2019 | 44 | 0.080 |
Why?
|
| Syndactyly | 1 | 2008 | 24 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 722 | 0.080 |
Why?
|
| RNA Editing | 1 | 2008 | 34 | 0.080 |
Why?
|
| Mice, Mutant Strains | 4 | 2011 | 384 | 0.080 |
Why?
|
| Protozoan Proteins | 3 | 2004 | 108 | 0.080 |
Why?
|
| Lasers | 1 | 2009 | 114 | 0.070 |
Why?
|
| K562 Cells | 2 | 2019 | 95 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2008 | 8 | 0.070 |
Why?
|
| Extremities | 1 | 2008 | 83 | 0.070 |
Why?
|
| Somatomedins | 1 | 2008 | 36 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 467 | 0.070 |
Why?
|
| Trastuzumab | 2 | 2019 | 134 | 0.070 |
Why?
|
| Vaccination | 1 | 2013 | 953 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2016 | 3753 | 0.070 |
Why?
|
| Hypothalamic Diseases | 1 | 2008 | 37 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 770 | 0.070 |
Why?
|
| Oleic Acid | 1 | 2007 | 15 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 135 | 0.070 |
Why?
|
| Biological Clocks | 1 | 2007 | 28 | 0.070 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2007 | 36 | 0.070 |
Why?
|
| Penetrance | 3 | 2012 | 103 | 0.070 |
Why?
|
| Lithium Carbonate | 1 | 2007 | 21 | 0.070 |
Why?
|
| Platelet Count | 2 | 2019 | 136 | 0.070 |
Why?
|
| DiGeorge Syndrome | 1 | 2008 | 79 | 0.070 |
Why?
|
| Curcumin | 1 | 2007 | 41 | 0.070 |
Why?
|
| Schwann Cells | 1 | 2007 | 59 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 284 | 0.070 |
Why?
|
| Myelin Proteins | 1 | 2007 | 76 | 0.070 |
Why?
|
| Antimanic Agents | 1 | 2007 | 37 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 170 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 670 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 183 | 0.070 |
Why?
|
| Angelman Syndrome | 1 | 2007 | 69 | 0.070 |
Why?
|
| Genes, tat | 1 | 2006 | 10 | 0.070 |
Why?
|
| Heterochromatin | 1 | 2006 | 49 | 0.070 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 137 | 0.070 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2006 | 22 | 0.070 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2006 | 27 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2018 | 551 | 0.070 |
Why?
|
| Cell Separation | 3 | 2018 | 229 | 0.070 |
Why?
|
| Body Composition | 1 | 2009 | 524 | 0.070 |
Why?
|
| Retroviridae | 1 | 2006 | 198 | 0.070 |
Why?
|
| Genetic Counseling | 3 | 2017 | 221 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2706 | 0.060 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2007 | 146 | 0.060 |
Why?
|
| Cyclins | 1 | 2006 | 101 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 113 | 0.060 |
Why?
|
| Hair Diseases | 1 | 2005 | 14 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 254 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2015 | 3288 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 137 | 0.060 |
Why?
|
| Protein Biosynthesis | 3 | 2016 | 665 | 0.060 |
Why?
|
| Heterografts | 2 | 2017 | 178 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2007 | 360 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2005 | 5 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2013 | 400 | 0.060 |
Why?
|
| Anxiety | 1 | 2012 | 966 | 0.060 |
Why?
|
| Periodicity | 1 | 2005 | 55 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 307 | 0.060 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 112 | 0.060 |
Why?
|
| Cranial Sutures | 1 | 2005 | 32 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2014 | 973 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2016 | 6139 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 1964 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 285 | 0.060 |
Why?
|
| Cell Cycle | 4 | 2011 | 615 | 0.060 |
Why?
|
| Jejunum | 1 | 2005 | 129 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 459 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 1900 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 376 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 354 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2017 | 571 | 0.060 |
Why?
|
| Hypoglycemia | 2 | 2017 | 194 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2009 | 778 | 0.060 |
Why?
|
| Monocytes | 1 | 2006 | 354 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 510 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2006 | 351 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2014 | 369 | 0.050 |
Why?
|
| Monosomy | 1 | 2003 | 24 | 0.050 |
Why?
|
| SOXF Transcription Factors | 1 | 2023 | 18 | 0.050 |
Why?
|
| Aged | 4 | 2018 | 19697 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2010 | 823 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 252 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6522 | 0.050 |
Why?
|
| Endothelium | 1 | 2023 | 72 | 0.050 |
Why?
|
| Meiosis | 1 | 2003 | 115 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2024 | 313 | 0.050 |
Why?
|
| Risk Factors | 2 | 2014 | 10275 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 320 | 0.050 |
Why?
|
| Trans-Activators | 3 | 2016 | 809 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2006 | 940 | 0.050 |
Why?
|
| Asthma | 1 | 2010 | 743 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2002 | 34 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 315 | 0.050 |
Why?
|
| Proteins | 2 | 2011 | 1045 | 0.050 |
Why?
|
| Risk | 2 | 2015 | 757 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 467 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 175 | 0.050 |
Why?
|
| Protein Interaction Maps | 2 | 2013 | 79 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 385 | 0.050 |
Why?
|
| Macrophages | 1 | 2006 | 618 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 189 | 0.050 |
Why?
|
| Apoptosis | 3 | 2019 | 1792 | 0.050 |
Why?
|
| Stem Cells | 1 | 2006 | 702 | 0.050 |
Why?
|
| Diaphragm | 1 | 2022 | 98 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 575 | 0.050 |
Why?
|
| Critical Care | 2 | 2017 | 654 | 0.050 |
Why?
|
| Length of Stay | 2 | 2017 | 1311 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 246 | 0.050 |
Why?
|
| Age of Onset | 2 | 2013 | 583 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 456 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 2 | 2011 | 123 | 0.040 |
Why?
|
| Siblings | 2 | 2012 | 196 | 0.040 |
Why?
|
| Embryonic Development | 2 | 2017 | 210 | 0.040 |
Why?
|
| Linear Models | 1 | 2002 | 677 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 316 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2143 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1189 | 0.040 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 545 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 809 | 0.040 |
Why?
|
| Genes, Protozoan | 3 | 2004 | 25 | 0.040 |
Why?
|
| Rats | 4 | 2007 | 3693 | 0.040 |
Why?
|
| Ataxin-7 | 2 | 2010 | 14 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2017 | 834 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2002 | 644 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2016 | 762 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 63 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 577 | 0.040 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2019 | 6 | 0.040 |
Why?
|
| Lymphangioma, Cystic | 1 | 2019 | 16 | 0.040 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2019 | 18 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2011 | 66 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 48 | 0.040 |
Why?
|
| Time Factors | 4 | 2013 | 6312 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2017 | 1152 | 0.040 |
Why?
|
| Achondroplasia | 1 | 2019 | 23 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 28 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 122 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2011 | 58 | 0.040 |
Why?
|
| Receptor, PAR-1 | 1 | 2018 | 3 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2015 | 627 | 0.040 |
Why?
|
| Hospitalization | 2 | 2018 | 1782 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2019 | 75 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 166 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2019 | 112 | 0.040 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2019 | 44 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 238 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 366 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2008 | 260 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 61 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 86 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 55 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 123 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
| Veratrum Alkaloids | 1 | 2017 | 11 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 133 | 0.040 |
Why?
|
| GATA1 Transcription Factor | 1 | 2017 | 9 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 309 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 49 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2017 | 39 | 0.030 |
Why?
|
| Chondrocytes | 2 | 2008 | 48 | 0.030 |
Why?
|
| Haemophilus | 1 | 2016 | 13 | 0.030 |
Why?
|
| Consanguinity | 1 | 2017 | 104 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 89 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 2016 | 43 | 0.030 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 150 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2013 | 867 | 0.030 |
Why?
|
| Viral Fusion Proteins | 1 | 2017 | 77 | 0.030 |
Why?
|
| RNA Stability | 2 | 2008 | 84 | 0.030 |
Why?
|
| Perfusion | 2 | 2007 | 203 | 0.030 |
Why?
|
| Chromatin | 2 | 2012 | 555 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 117 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 101 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2017 | 67 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 166 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 114 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 263 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 134 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 263 | 0.030 |
Why?
|
| Quinazolines | 1 | 2017 | 176 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 474 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 214 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2015 | 28 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 393 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 211 | 0.030 |
Why?
|
| Common Cold | 1 | 2015 | 24 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 62 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 50 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 38 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2015 | 59 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2008 | 486 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2015 | 80 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 67 | 0.030 |
Why?
|
| Ischemia | 1 | 2018 | 357 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2015 | 80 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 1069 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2018 | 468 | 0.030 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 40 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2009 | 1017 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 350 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2006 | 286 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 301 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 555 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2015 | 89 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 309 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 115 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 388 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 179 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2015 | 139 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 372 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 226 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 791 | 0.030 |
Why?
|
| Embolism, Cholesterol | 1 | 2013 | 3 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 372 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2007 | 381 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 56 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 521 | 0.030 |
Why?
|
| Poland | 1 | 2013 | 47 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 316 | 0.030 |
Why?
|
| Microcephaly | 1 | 2017 | 332 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 170 | 0.030 |
Why?
|
| Ribosomes | 1 | 2014 | 138 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 227 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 91 | 0.030 |
Why?
|
| Age Factors | 2 | 2014 | 2820 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 796 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2013 | 36 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 550 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 405 | 0.030 |
Why?
|
| Base Composition | 1 | 2013 | 71 | 0.030 |
Why?
|
| Rotavirus | 1 | 2017 | 497 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 43 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 1030 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 399 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1252 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 834 | 0.030 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2013 | 58 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 107 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 504 | 0.030 |
Why?
|
| Hypothermia | 1 | 2013 | 56 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 331 | 0.030 |
Why?
|
| Cell Division | 1 | 2014 | 782 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 165 | 0.030 |
Why?
|
| Base Pairing | 1 | 2012 | 43 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2013 | 247 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2012 | 29 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 426 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 79 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2014 | 363 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 6 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 256 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 184 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 426 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 476 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 80 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 753 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 85 | 0.020 |
Why?
|
| Corticosterone | 1 | 2012 | 59 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 269 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 323 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 333 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 106 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 294 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2011 | 63 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2011 | 65 | 0.020 |
Why?
|
| Glucose | 2 | 2007 | 885 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 35 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2011 | 17 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 144 | 0.020 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 582 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 1028 | 0.020 |
Why?
|
| Models, Biological | 2 | 2008 | 1461 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 255 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 145 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 237 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 78 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 253 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 375 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 36 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 676 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 199 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2012 | 151 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 419 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2012 | 224 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1691 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2004 | 1075 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 165 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 256 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 247 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 465 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1285 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2012 | 407 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 297 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 504 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 324 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 537 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12342 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 284 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 13 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 107 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 56 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 97 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 26 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2012 | 198 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 356 | 0.020 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2008 | 6 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2008 | 26 | 0.020 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2008 | 34 | 0.020 |
Why?
|
| United States | 2 | 2016 | 10876 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 124 | 0.020 |
Why?
|
| RNA, Small Untranslated | 1 | 2008 | 21 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 27 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 209 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2902 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 144 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 238 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2011 | 352 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 435 | 0.020 |
Why?
|
| Telemetry | 1 | 2007 | 27 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Tretinoin | 1 | 2008 | 117 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 109 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 184 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 48 | 0.020 |
Why?
|
| PAX6 Transcription Factor | 1 | 2007 | 37 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2009 | 156 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2008 | 90 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2007 | 28 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 60 | 0.020 |
Why?
|
| Family | 1 | 2011 | 565 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 75 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 293 | 0.020 |
Why?
|
| Glycogenolysis | 1 | 2007 | 10 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2007 | 31 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2007 | 56 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 96 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 41 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2007 | 9 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2009 | 298 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 11 | 0.020 |
Why?
|
| Retina | 1 | 2010 | 453 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 74 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 63 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2007 | 58 | 0.020 |
Why?
|
| Medicare | 1 | 2010 | 424 | 0.020 |
Why?
|
| Cognition | 1 | 2012 | 731 | 0.020 |
Why?
|
| P-Selectin | 1 | 2007 | 78 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 824 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 64 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2007 | 92 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 120 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 93 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2007 | 153 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 128 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2007 | 195 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2006 | 25 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 18 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2007 | 125 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 69 | 0.020 |
Why?
|
| Cyclin T | 1 | 2006 | 34 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 493 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 443 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 359 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2006 | 56 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2007 | 219 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2007 | 146 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 323 | 0.020 |
Why?
|
| RNA, Ribosomal, 5.8S | 1 | 2005 | 6 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2006 | 100 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2007 | 453 | 0.020 |
Why?
|
| Drug Resistance, Multiple | 1 | 2005 | 49 | 0.020 |
Why?
|
| Uncoupling Protein 3 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 713 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2005 | 70 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2005 | 12 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 1532 | 0.020 |
Why?
|
| Dendrites | 1 | 2007 | 204 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2005 | 39 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2005 | 29 | 0.020 |
Why?
|
| Animals, Suckling | 1 | 2005 | 50 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2005 | 21 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 683 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2007 | 457 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1604 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1239 | 0.010 |
Why?
|
| Myosin Type I | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cellulase | 1 | 2004 | 3 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2005 | 176 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 595 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 370 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 1005 | 0.010 |
Why?
|
| Spores, Protozoan | 1 | 2004 | 18 | 0.010 |
Why?
|
| RNA, Protozoan | 1 | 2004 | 10 | 0.010 |
Why?
|
| Fasting | 1 | 2006 | 303 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2007 | 418 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 1142 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 76 | 0.010 |
Why?
|
| Binding Sites | 1 | 2007 | 1297 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2006 | 241 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 208 | 0.010 |
Why?
|
| Leukocytes | 1 | 2005 | 206 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 488 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1751 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2009 | 646 | 0.010 |
Why?
|
| Ion Channels | 1 | 2005 | 194 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 578 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 523 | 0.010 |
Why?
|
| Memory | 1 | 2007 | 362 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2005 | 275 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 573 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5156 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2003 | 38 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 334 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 88 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 690 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 250 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 1428 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 724 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 414 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 219 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 200 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 1052 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2003 | 212 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 974 | 0.010 |
Why?
|
| Genome, Protozoan | 1 | 2002 | 26 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 803 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 389 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1341 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3589 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 1175 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 654 | 0.010 |
Why?
|
| Hippocampus | 1 | 2007 | 830 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 568 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 768 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 1290 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1395 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 3447 | 0.010 |
Why?
|